Liver transplantation in Germany

Frank Tacke, Daniela C. Kroy, Ana Paula Barreiros, Ulf P. Neumann – 15 April 2016 – Liver transplantation (LT) is a well‐accepted procedure for end‐stage liver disease in Germany. In 2015, 1489 patients were admitted to the waiting list (including 1308 new admissions), with the leading etiologies being fibrosis and cirrhosis (n = 349), alcoholic liver disease (n = 302), and hepatobiliary malignancies (n = 220). Organ allocation in Germany is regulated within the Eurotransplant system based on urgency as expressed by the Model for End‐Stage Liver Disease score.

Liver transplantation in the United Kingdom

James Neuberger – 15 April 2016 – Liver transplantation (LT) services in the United Kingdom are provided by 7 designated transplant centers for a population of approximately 64 million. The number of deceased organ donors has grown, and in 2014‐2015 it was 1282 (570 donation after circulatory death and 772 donation after brain death). Donor risk is increasing. In 2014‐2015, there were 829 LTs from deceased and 38 from living donors. The common causes for transplantation are liver cell cancer, viral hepatitis, and alcohol‐related liver disease.

Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression

Jessica Liu, Hwai‐I Yang, Mei‐Hsuan Lee, Chin‐Lan Jen, Richard Batrla‐Utermann, Sheng‐Nan Lu, Li‐Yu Wang, San‐Lin You, Chien‐Jen Chen – 15 April 2016 – Serum levels of hepatitis B virus (HBV) DNA (≤2000 IU/mL) and hepatitis B surface antigen (HBsAg) (<1000 IU/mL) have been shown to distinguish inactive carriers with high accuracy. The goal of this study was to validate the predictability of one‐time measurement of quantitative HBsAg and HBV DNA levels for inactive carrier status and chronic hepatitis B (CHB) progression in a community‐based cohort.

Randomized, open‐label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma

Ann‐Lii Cheng, Sumitra Thongprasert, Ho Yeong Lim, Wattana Sukeepaisarnjaroen, Tsai‐Shen Yang, Cheng‐Chung Wu, Yee Chao, Stephen L. Chan, Masatoshi Kudo, Masafumi Ikeda, Yoon‐Koo Kang, Hongming Pan, Kazushi Numata, Guohong Han, Binaifer Balsara, Yong Zhang, Ana‐Marie Rodriguez, Yi Zhang, Yongyu Wang, Ronnie T. P.

Liver transplantation in Ireland

Masood Iqbal, Elgaily A. Elrayah, Oscar Traynor, P. Aiden McCormick – 11 April 2016 – The Irish National Liver Transplant program commenced in 1993 in St. Vincent's University Hospital in Dublin. It is an adult‐only program and is the only liver transplant program in Ireland. Pediatric recipients are referred to King's College Hospital in the United Kingdom. To date, almost 1000 adult liver transplants have been performed. Current 1‐year patient survival is 93%, and 5‐year survival is 79%. The program is fully funded by the government health service.

Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients

Pratima Sharma, Neehar D. Parikh, Jessica Yu, Pranab Barman, Brian A. Derstine, Christopher J. Sonnenday, Stewart C. Wang, Grace L. Su – 11 April 2016 – Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Recent data suggest that body composition features strongly affect post‐LT mortality. We examined the impact of body composition on post‐LT mortality in patients with HCC.

Subscribe to